Understanding the Particokinetics of Engineered Nanomaterials for Safe and Effective Therapeutic Applications

被引:32
作者
Zhu, Motao [1 ]
Perrett, Sarah [2 ]
Nie, Guangjun [1 ]
机构
[1] Chinese Acad Sci, Key Lab Biomed Effects Nanomat & Nanosafety, Natl Ctr Nanosci & Technol China, Beijing 100190, Peoples R China
[2] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China
基金
中国国家自然科学基金;
关键词
nanomaterials; particokinetics; biological behavior; nanoparticle kinetics; BLOOD-BRAIN-BARRIER; MESOPOROUS SILICA NANOPARTICLES; IN-VIVO BIODISTRIBUTION; TARGETED DRUG-DELIVERY; SUSTAINED-RELEASE; CARBON NANOTUBES; CELLULAR UPTAKE; GOLD NANOPARTICLES; PLGA NANOPARTICLES; PARTICLE-SIZE;
D O I
10.1002/smll.201201630
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Increasing numbers of engineered nanomaterials (ENMs) are being developed for therapeutic and diagnostic applications. However, the tunable and varied physicochemical properties of ENMs pose a new challenge for understanding their biological behavior, trafficking, and biodistribution. Herein the concept of particokinetics is introduced to address the dynamic biological behavior of ENMs at the molecular level (including gravitational sedimentation, dispersion, aggregation, and interaction with biomolecules in suspending media), cellular level (including cellular uptake, transport, biotransformation, and elimination), and whole-organism level (including absorption, distribution, metabolism, and excretion in vivo). Several mathematical modeling methods are introduced which guide a quantitative description of their biological behavior at different levels. Examples are also provided to delineate the impact of the physicochemical properties of ENMs on their particokinetics. A comprehensive understanding of the in vivo and in vitro particokinetics of ENMs will facilitate the design of tailor-made functional ENMs that act as highly effective and controllable drug-delivery systems with minimal side-effects.
引用
收藏
页码:1619 / 1634
页数:16
相关论文
共 141 条
[1]   Effect of Gold Nanoparticle Aggregation on Cell Uptake and Toxicity [J].
Albanese, Alexandre ;
Chan, Warren C. W. .
ACS NANO, 2011, 5 (07) :5478-5489
[2]   Factors affecting the clearance and biodistribution of polymeric nanoparticles [J].
Alexis, Frank ;
Pridgen, Eric ;
Molnar, Linda K. ;
Farokhzad, Omid C. .
MOLECULAR PHARMACEUTICS, 2008, 5 (04) :505-515
[3]   Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier [J].
Andrieux, Karine ;
Couvreur, Patrick .
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2009, 1 (05) :463-474
[4]  
[Anonymous], 1994, Ann ICRP, V24, P1
[5]  
[Anonymous], 1960, Transport Phenomena
[6]   Artificial viruses and their application to gene delivery. size-controlled gene coating with glycocluster nanoparticles [J].
Aoyama, Y ;
Kanamori, T ;
Nakai, T ;
Sasaki, T ;
Horiuchi, S ;
Sando, S ;
Niidome, T .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (12) :3455-3457
[7]   Nanoparticles: transport across the olfactory epithelium and application to the assessment of brain function in health and disease [J].
Aschner, Michael .
NANONEUROSCIENCE AND NANONEUROPHARMACOLOGY, 2009, 180 :141-152
[8]   Nanoparticle-Mediated Cytoplasmic Delivery of Proteins To Target Cellular Machinery [J].
Bale, Shyam Sundhar ;
Kwon, Seok Joon ;
Shah, Dhiral A. ;
Banerjee, Akhilesh ;
Dordick, Jonathan S. ;
Kane, Ravi S. .
ACS NANO, 2010, 4 (03) :1493-1500
[9]   The impact of nanoparticle ligand density on dendritic-cell targeted vaccines [J].
Bandyopadhyay, Arunima ;
Fine, Rebecca L. ;
Demento, Stacey ;
Bockenstedt, Linda K. ;
Fahmy, Tarek M. .
BIOMATERIALS, 2011, 32 (11) :3094-3105
[10]   Toxicity Assessments of Multisized Gold and Silver Nanoparticles in Zebrafish Embryos [J].
Bar-Ilan, Ofek ;
Albrecht, Ralph M. ;
Fako, Valerie E. ;
Furgeson, Darin Y. .
SMALL, 2009, 5 (16) :1897-1910